First Financial Bankshares’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.2M Buy
433,584
+61,763
+17% +$1.64M 0.25% 66
2025
Q4
$9.26M Sell
371,821
-54,776
-13% -$1.38M 0.19% 65
2025
Q3
$10.9M Buy
426,597
+9,050
+2% +$223K 0.22% 63
2025
Q2
$10.1M Buy
417,547
+1,377
+0.3% +$32.1K 0.23% 66
2025
Q1
$10.5M Buy
416,170
+18,696
+5% +$489K 0.23% 66
2024
Q4
$10.5M Sell
397,474
-14,695
-4% -$399K 0.23% 65
2024
Q3
$11.9M Buy
412,169
+1,334
+0.3% +$38.9K 0.25% 64
2024
Q2
$11.5M Buy
410,835
+4,824
+1% +$133K 0.26% 64
2024
Q1
$11.3M Buy
406,011
+96,818
+31% +$2.69M 0.25% 65
2023
Q4
$8.9M Buy
+309,193
New +$9.35M 0.21% 69

Other funds holding PFE

First Financial Bankshares's PFE Position: Q1 2026 in Review

First Financial Bankshares increased its Pfizer (PFE) stake by 17% in Q1 2026, buying an estimated $1.64M and bringing the position to 433,584 shares worth $12.2M. The position accounts for 0.25% of the portfolio, ranked #66.

First Financial Bankshares first reported a position in PFE in Q4 2023 and has held it in 10 quarters since. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • First Financial Bankshares held 433,584 shares of Pfizer worth $12.2M as of Q1 2026.
  • First Financial Bankshares bought 61,763 Pfizer shares in Q1 2026, an estimated $1.64M.
  • Pfizer made up 0.25% of First Financial Bankshares's portfolio in Q1 2026, its #66 holding.
  • First Financial Bankshares first reported a position in Pfizer in Q4 2023 and has held it in 10 quarters since.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on First Financial Bankshares's 13F filing for Q1 2026, filed 11 May 2026.